SolasCure
Latest round
- Series B
Last raised
- Mar 2023
Total raised
- $34M
Investors
- 6
About SolasCure
Founded in 2017 and based in Cambridge, UK, SolasCure Limited also known as AURASE, is a biotechnology company developing wound care products for different chronic wounds. The company is a spin-off from BRAIN Biotech AG, a German biotech company that focuses on harnessing biological diversity to develop various innovative solutions. It was founded by its CEO Dr. Sam Bakri, along with Benjamin Newmark. Dr. Bakri also served as the CEO and co-founder of Kind Consumer, co-founder of AIDA Health, and as a Vice-Chairman of Gelmetix Healthcare. The company develops Aurase®, a hydrogel containing an enzyme cloned from medical maggots that helps in the acceleration of wound cleaning for various chronic wounds. It aims to provide a solution to painful or inadequate debridement procedures such as surgical or autolytic debridement for setting that includes hospitals, nursing homes, or home care. The company's revenue is generated by the sales of its therapeutic product for medical use.
Who invested in SolasCure
6 investors across 2 rounds
See all investors in SolasCure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SolasCure
Who invested in SolasCure?
SolasCure has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SolasCure raised?
SolasCure has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SolasCure last raise money?
SolasCure's most recent round on record is a Series B, in Mar 2023.
What does SolasCure do?
Founded in 2017 and based in Cambridge, UK, SolasCure Limited also known as AURASE, is a biotechnology company developing wound care products for different chronic wounds.
Where is SolasCure headquartered?
SolasCure is headquartered in Cambridge, UK.
Which VCs invest in companies like SolasCure?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at SolasCure's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like SolasCure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.